{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:08:52Z","timestamp":1764058132799,"version":"3.45.0"},"reference-count":95,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"BMS Poland"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/14737140.2025.2557610","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T11:01:44Z","timestamp":1757934104000},"page":"1369-1389","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of first-line immune checkpoint inhibitors in patients with PD-L1 &lt;1% metastatic non-small-cell lung cancer \u2013 implications for daily clinical practice"],"prefix":"10.1080","volume":"25","author":[{"given":"Maciej","family":"Bryl","sequence":"first","affiliation":[{"name":"E. J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery","place":["Poznan, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Stencel","sequence":"additional","affiliation":[{"name":"E. J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery","place":["Poznan, Poland"]},{"name":"Polish Mother\u2019s Memorial Hospital - Research Institute","place":["\u0141\u00f3d\u017a, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Knetki-Wr\u00f3blewska","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology","place":["Warsaw, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Krzakowski","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology","place":["Warsaw, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.013"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw378.14"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.06.012"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03136"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.06.015"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30641-0"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02201-8"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2022.10.003"},{"key":"e_1_3_6_11_1","unstructured":"Regeneron. Libtayo\u00ae (cemiplimab): Summary of product characteristics. 2024 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/libtayo-epar-product-information_en.pdf"},{"key":"e_1_3_6_12_1","unstructured":"Regeneron Pharmaceuticals. Libtayo\u00ae (cemiplimab-rwlc): US prescribing information. 2024 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761097s023lbl.pdf"},{"key":"e_1_3_6_13_1","unstructured":"Bristol-Myers Squibb Company. Opdivo (nivolumab): US prescribing information. 2025 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/125554s129lbl.pdf"},{"key":"e_1_3_6_14_1","unstructured":"Merck Sharp & Dohme. Keytruda (pembrolizumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/keytruda-epar-product-information_en.pdf"},{"key":"e_1_3_6_15_1","unstructured":"Merck Sharp & Dohme. Keytruda\u00ae (pembrolizumab): US prescribing information. 2025 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/125514s174lbl.pdf"},{"key":"e_1_3_6_16_1","unstructured":"Junshi Pharma. Toripalimab. 2023 Available from: https:\/\/www.junshipharma.com\/en\/rd-pipeline\/#medical-content"},{"key":"e_1_3_6_17_1","unstructured":"Roche Pharma. Tecentriq\u00ae (atezolizumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tecentriq-epar-product-information_en.pdf"},{"key":"e_1_3_6_18_1","unstructured":"Genentech Inc. Tecentriq\u00ae (atezolizumab): US prescribing information. 2024 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761034s053lbl.pdf"},{"key":"e_1_3_6_19_1","unstructured":"AstraZeneca. Imfinzi (durvalumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imfinzi-epar-product-information_en.pdf"},{"key":"e_1_3_6_20_1","unstructured":"AstraZeneca Pharmaceuticals. Imfinzi\u00ae (durvalumab): US prescribing information. 2025 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761069s050lbl.pdf"},{"key":"e_1_3_6_21_1","unstructured":"Bristol-Myers Squibb Pharma. Yervoy (ipilimumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/yervoy-epar-product-information_en.pdf"},{"key":"e_1_3_6_22_1","unstructured":"Bristol-Myers Squibb Company. Yervoy\u00ae (ipilimumab): US prescribing information. 2025 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/125377s133lbl.pdf"},{"key":"e_1_3_6_23_1","unstructured":"AstraZeneca. Imjudo\u00ae (tremelimumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imjudo-epar-product-information_en.pdf"},{"key":"e_1_3_6_24_1","unstructured":"AstraZeneca Pharmaceuticals. Imjudo\u00ae (tremelimumab-actl): US prescribing information. 2024 Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761289s004lbl.pdf"},{"key":"e_1_3_6_25_1","unstructured":"Bristol-Myers Squibb Pharma. Opdivo (nivolumab): Summary of product characteristics. 2025 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/opdivo-epar-product-information_en.pdf"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.12.107"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12662"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03030-8"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00412"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.013"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00975"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810865"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1507"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8172"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30167-6"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.03.028"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.11.025"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30365-9"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.018"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.03.008"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00650-1"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00578-z"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01977-y"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102065"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.04.008"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01989"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01990"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33142"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.06.020"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.04.011"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.04.011"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.07.014"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.07.013"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00727"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02087-6"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.05.005"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103728"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0366"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103727"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.009"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.1381"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0237"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.09.223"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006127"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.06.004"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100273"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.10.014"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008189"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114296"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910231"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.09.010"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01503"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv383"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.554313"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.1175"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.657545"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.03.016"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4405"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2021-0208"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100465"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.2027"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02446"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00174"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.08.004"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00059"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0715"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00720"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1556-0864(23)00267-8"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00338-9"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.e21077"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2016.5"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225394"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-023-01185-y"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elad031"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2025.2557610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:06:27Z","timestamp":1764057987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2025.2557610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":95,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/14737140.2025.2557610"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2025.2557610","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"type":"print","value":"1473-7140"},{"type":"electronic","value":"1744-8328"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}